Antares pharma reports fourth quarter and full year 2019 operating and financial results

Record quarterly revenue of $37.8 million – earnings per share of $0.03 record annual revenue of $123.9 million, a 95% increase over 2018 annual revenue ...

ATRS Ratings Summary

ATRS Quant Ranking